
ETF Channel analysis indicates the First Trust Nasdaq BuyWrite Income ETF (FTQI) has an implied analyst target price of $22.17, suggesting a 10.32% upside from its recent $20.10 trading price, based on the weighted average of its underlying holdings' analyst targets. This potential is significantly influenced by key constituents like Icahn Enterprises LP (IEP), Genmab A/S (GMAB), and Kaspi KZ JSC (KSPI), which show individual analyst target upsides of 42.69%, 30.44%, and 19.86% respectively. The findings highlight considerable upside potential for FTQI according to current analyst consensus, warranting further investor scrutiny into the validity of these targets.
The First Trust Nasdaq BuyWrite Income ETF (FTQI) exhibits a notable 10.32% potential upside, based on a weighted average of analyst 12-month forward price targets for its underlying holdings, implying a target of $22.17 per unit against a recent price of $20.10. This implied upside is heavily influenced by bullish analyst sentiment on key individual holdings. Specifically, Icahn Enterprises LP (IEP) shows a projected 42.69% upside to a $12.00 target, Genmab A/S (GMAB) has a 30.44% upside to $31.07, and Kaspi KZ JSC (KSPI) has a 19.86% upside to $112.75. While these figures suggest a strong positive outlook, the analysis is presented with a significant caveat, questioning the justification for these targets and raising the possibility of them being overly optimistic or relics of past analysis. This introduces a layer of uncertainty, highlighting the risk that these targets could face downgrades if recent company or industry developments are not favorable, a possibility that requires further investor research to validate.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
Neutral
Sentiment Score
0.10
Ticker Sentiment